Also listed under Colonic Diseases, Rectal Diseases
ClinicalTrials.gov term: Colorectal Neoplasms
202 trials changed in the last 30 days: 5 stopped, 88 with notable changes, 109 with minor changes only.
Trial terminated
Also in this update: Final enrollment: 14 participants (planned 135)
Boehringer IngelheimPhase 1 NCT06882746 Registry history of NCT06882746 on ClinicalTrials.gov (opens the registry)
Withdrawn before enrolling
Biotech Pharmaceutical Co., Ltd.Phase 3 NCT06343116 Registry history of NCT06343116 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Primary completion date changed from estimate of Aug 2030 to Jul 31, 2026; Final enrollment: 215 participants (planned 550)
Ralf HofheinzPhase 3 NCT04495088 Registry history of NCT04495088 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
University of Alabama at BirminghamPhase 1 NCT06867822 Registry history of NCT06867822 on ClinicalTrials.gov (opens the registry)
Trial status changed: Active, Not Recruiting → Suspended
Also in this update: Primary and study completion pushed from Jun 2026 to Mar 2027
Weill Medical College of Cornell UniversityNot applicable NCT03623464 Registry history of NCT03623464 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jan 10, 2028 to Jan 9, 2029
Also in this update: Enrollment reduced: 451 → 346 participants; Interventions modified
GlaxoSmithKlinePhase 1/2 NCT06885034 Registry history of NCT06885034 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 30, 2026 to Jun 25, 2027
Also in this update: Study completion pushed from Oct 31, 2026 to Jun 25, 2027
Novartis PharmaceuticalsPhase 1 NCT03891953 Registry history of NCT03891953 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 2027 to Nov 2028
Also in this update: Primary endpoint(s) modified; Enrollment increased: 294 → 344 participants
Jacobio Pharmaceuticals Co., Ltd.Phase 1/2 NCT06973564 Registry history of NCT06973564 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 1, 2026 to Sep 30, 2029
Also in this update: Study completion pushed from Mar 1, 2028 to Sep 30, 2030
Fudan UniversityPhase 2 NCT06841159 Registry history of NCT06841159 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from May 27, 2027 to Dec 16, 2028
City of Hope Medical CenterPhase 2 NCT07595874 Registry history of NCT07595874 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 2026 to Nov 2026
Bexion Pharmaceuticals, Inc.Phase 1/2 NCT05322590 Registry history of NCT05322590 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 2026 to Jun 30, 2027
Also in this update: Sponsor changed: Suzhou Transcenta Therapeutics Co., Ltd. to Transcenta Therapeutics (Hangzhou) Co., Ltd.; Study completion pushed from Dec 2026 to Sep 30, 2027
Transcenta Therapeutics (Hangzhou) Co., Ltd.Phase 1/2 NCT05731271 Registry history of NCT05731271 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 15, 2027 to Sep 30, 2028
Also in this update: Primary endpoint(s) modified; Interventions modified
Revolution Medicines, Inc.Phase 1/2 NCT06445062 Registry history of NCT06445062 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 29, 2025 to Nov 29, 2026
MiWEndo Solutions S.L.Not applicable NCT05988645 Registry history of NCT05988645 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Oct 31, 2027
Also in this update: Enrollment increased: 292 → 473 participants; Study completion pushed from Jun 1, 2027 to Mar 30, 2028
Bicara TherapeuticsPhase 1 NCT04429542 Registry history of NCT04429542 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 13, 2026 to Feb 14, 2028
Also in this update: Trial sites expanded: 6 → 22 locations; Study completion pushed from Sep 29, 2028 to May 1, 2030
GlaxoSmithKlinePhase 1 NCT07277270 Registry history of NCT07277270 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 1, 2027 to Jun 1, 2029
Roswell Park Cancer InstitutePhase 1/2 NCT06307548 Registry history of NCT06307548 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Dec 2027
Also in this update: Study completion pushed from Dec 2026 to Jan 2028
HealthPartners InstitutePhase 2 NCT06605430 Registry history of NCT06605430 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 2026 to Jul 2027
Also in this update: Enrollment closed, study ongoing; Trial sites reduced: 8 → 5 locations
Instituto do Cancer do Estado de São PauloPhase 2 NCT06638931 Registry history of NCT06638931 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 2027 to Apr 2028
Also in this update: Primary endpoint(s) modified; Enrollment increased: 145 → 545 participants
Kestrel Therapeutics, Inc.Phase 1 NCT07458347 Registry history of NCT07458347 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites expanded: 1 → 27 locations
3D Medicines (Sichuan) Co., Ltd.Phase 2 NCT03667170 Registry history of NCT03667170 on ClinicalTrials.gov (opens the registry)
Trial completed
Toray Industries, IncPhase 1 NCT03872947 Registry history of NCT03872947 on ClinicalTrials.gov (opens the registry)
Trial completed
Oslo University HospitalPhase 2/3 NCT03326791 Registry history of NCT03326791 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 25 participants (planned 40)
Novartis PharmaceuticalsPhase 1/2 NCT07468071 Registry history of NCT07468071 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 31, 2026 to Jan 31, 2027
MediLink Therapeutics (Suzhou) Co., Ltd.Phase 2 NCT07202364 Registry history of NCT07202364 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Averto Medical, Inc.Not applicable NCT07429110 Registry history of NCT07429110 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Oct 1, 2026 to Sep 1, 2026; Final enrollment: 1334 participants (planned 1020)
Dana-Farber Cancer InstituteNot applicable NCT05225428 Registry history of NCT05225428 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 30, 2026 to Nov 30, 2026
Also in this update: Enrollment increased: 115 → 160 participants; Study completion pushed from Dec 30, 2026 to Dec 30, 2028
Medicenna Therapeutics, Inc.Phase 1/2 NCT05086692 Registry history of NCT05086692 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jul 2026 to Sep 2026
Sun Yat-sen UniversityNot applicable NCT02966483 Registry history of NCT02966483 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Jan 2027 to Sep 30, 2026; Final enrollment: 15128 participants (planned 6000)
University of ArizonaNot applicable NCT06542835 Registry history of NCT06542835 on ClinicalTrials.gov (opens the registry)
Trial completed
Baylor Research InstituteNot specified NCT04751448 Registry history of NCT04751448 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 30, 2026 to May 6, 2025
National Cancer Institute (NCI)Phase 1/2 NCT04708470 Registry history of NCT04708470 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
Also in this update: Final enrollment: 119 participants (planned 300)
M.D. Anderson Cancer CenterPhase 1 NCT02600949 Registry history of NCT02600949 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Sep 2025 to Mar 17, 2025; Final enrollment: 872 participants (planned 616)
Jichao QinNot applicable NCT04999007 Registry history of NCT04999007 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Jul 2026 to Nov 14, 2024
Weill Medical College of Cornell UniversityPhase 2 NCT05571293 Registry history of NCT05571293 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion moved earlier from Dec 2028 to Dec 2027; Primary completion date changed from estimate of Dec 2026 to Aug 20, 2026
Georgetown UniversityPhase 3 NCT05482516 Registry history of NCT05482516 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 285 → 330 participants
ModeX Therapeutics, An OPKO Health CompanyPhase 1/2 NCT06239194 Registry history of NCT06239194 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2027 to Jul 18, 2025; Final enrollment: 20 participants (planned 24)
Barbara Ann Karmanos Cancer InstitutePhase 1 NCT05556473 Registry history of NCT05556473 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 1, 2029 to Nov 1, 2029
Sun Yat-sen UniversityPhase 2 NCT07621497 Registry history of NCT07621497 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Final enrollment: 30 participants (planned 25)
M.D. Anderson Cancer CenterPhase 2 NCT05343013 Registry history of NCT05343013 on ClinicalTrials.gov (opens the registry)
Trial completed
UNICANCERPhase 2 NCT02980510 Registry history of NCT02980510 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 364 → 404 participants
Astellas Pharma IncPhase 1 NCT07094204 Registry history of NCT07094204 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Jan 1, 2026 to Feb 28, 2025
Pennington Biomedical Research CenterNot applicable NCT03975491 Registry history of NCT03975491 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 2042 to Nov 2042
University of PennsylvaniaPhase 1 NCT07594067 Registry history of NCT07594067 on ClinicalTrials.gov (opens the registry)
Trial completed
Grigore T. Popa University of Medicine and PharmacyNot applicable NCT07237438 Registry history of NCT07237438 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of NebraskaNot applicable NCT05903885 Registry history of NCT05903885 on ClinicalTrials.gov (opens the registry)
Trial status changed: Unknown → Active, Not Recruiting
Also in this update: Study completion pushed from Dec 31, 2025 to Dec 31, 2030; Primary completion date changed from estimate of Jun 15, 2025 to May 7, 2025
Chinese University of Hong KongNot specified NCT05405673 Registry history of NCT05405673 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion date changed from estimate of Feb 19, 2026 to Sep 30, 2025
Francesco De CobelliNot specified NCT07385521 Registry history of NCT07385521 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 78 → 81 locations
And 1 more change in the last 30 days
AbbViePhase 2 NCT06820463 Registry history of NCT06820463 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 84 → 87 locations
And 1 more change in the last 30 days
AbbViePhase 3 NCT07525206 Registry history of NCT07525206 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 30, 2026 to Nov 2026
Also in this update: Study completion pushed from Sep 30, 2026 to Jan 2027
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2 NCT03796884 Registry history of NCT03796884 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 258 → 350 participants
Also in this update: Interventions modified
Phanes TherapeuticsPhase 1/2 NCT05482893 Registry history of NCT05482893 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 0 → 18 locations
Eli Lilly and CompanyPhase 2 NCT07814417 Registry history of NCT07814417 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 21 → 25 locations
Verastem, Inc.Phase 2 NCT07659795 Registry history of NCT07659795 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 1, 2028 to Nov 1, 2028
Mayo ClinicPhase 2 NCT07612007 Registry history of NCT07612007 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to May 1, 2027
Mayo ClinicPhase 2 NCT06265285 Registry history of NCT06265285 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 2028 to Oct 2028
Cedars-Sinai Medical CenterPhase 2 NCT06258525 Registry history of NCT06258525 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 18, 2026 to May 15, 2027
Mayo ClinicPhase 2 NCT07285044 Registry history of NCT07285044 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 167 → 190 participants
Also in this update: Primary completion date changed from estimate of Aug 3, 2028 to Jun 16, 2026
AstraZenecaPhase 1 NCT05647122 Registry history of NCT05647122 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 280 → 293 locations
Incyte CorporationPhase 3 NCT07284849 Registry history of NCT07284849 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 66 → 92 locations
EMD Serono Research & Development Institute, Inc.Phase 3 NCT07549412 Registry history of NCT07549412 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 348 → 372 locations
And 2 more changes in the last 30 days
PfizerPhase 3 NCT07222800 Registry history of NCT07222800 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 213 → 236 locations
Summit TherapeuticsPhase 3 NCT07228832 Registry history of NCT07228832 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 100 → 120 participants
National Cancer Institute (NCI)Phase 1 NCT06885697 Registry history of NCT06885697 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 239 → 243 locations
Merck Sharp & Dohme LLCPhase 3 NCT06997497 Registry history of NCT06997497 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 37 → 48 participants
Tang-Du HospitalNot applicable NCT07854964 Registry history of NCT07854964 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 16 locations
Perspective TherapeuticsPhase 1/2 NCT06710756 Registry history of NCT06710756 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 10 → 35 locations
Eikon TherapeuticsPhase 1/2 NCT07262619 Registry history of NCT07262619 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 3 → 16 locations
Blueprint Medicines CorporationPhase 1/2 NCT07629960 Registry history of NCT07629960 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 120 → 144 participants
Tao ZhangPhase 2 NCT07847229 Registry history of NCT07847229 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 3 → 7 locations
Avacta Life Sciences LtdPhase 1 NCT07454642 Registry history of NCT07454642 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 12 → 22 locations
Pliant Therapeutics, Inc.Phase 1 NCT06270706 Registry history of NCT06270706 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 8 → 12 locations
ALX Oncology Inc.Phase 1 NCT07085091 Registry history of NCT07085091 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 23 → 20 locations
AstraZenecaPhase 1 NCT05877599 Registry history of NCT05877599 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Aug 31, 2027 to Jun 30, 2026
GlaxoSmithKlinePhase 1 NCT05277051 Registry history of NCT05277051 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 118 → 173 participants
University of Southern CaliforniaNot specified NCT07259304 Registry history of NCT07259304 on ClinicalTrials.gov (opens the registry)
Enrollment reduced: 8946 → 6434 participants
Dartmouth-Hitchcock Medical CenterNot applicable NCT05612347 Registry history of NCT05612347 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 172 → 210 participants
Mälardalen UniversityNot applicable NCT06719206 Registry history of NCT06719206 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jul 31, 2026 to Oct 23, 2026
Mirati Therapeutics Inc.Phase 3 NCT04793958 Registry history of NCT04793958 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 467 → 486 locations
Wake Forest University Health SciencesNot specified NCT06418204 Registry history of NCT06418204 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Aug 2030 to Nov 2026
BioNTech SEPhase 2 NCT04486378 Registry history of NCT04486378 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 319 → 360 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07143487 Registry history of NCT07143487 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 364 → 368 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07283939 Registry history of NCT07283939 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 18 → 23 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07059884 Registry history of NCT07059884 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Oct 31, 2030 to May 11, 2031
Janssen Research & Development, LLCPhase 1/2 NCT05379595 Registry history of NCT05379595 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jun 30, 2026 to Dec 2026
Also in this update: Primary completion date changed from estimate of Jun 30, 2026 to Aug 14, 2026
Digital Health Navigation Solutions, IncNot applicable NCT06821009 Registry history of NCT06821009 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Oct 2, 2026 to Sep 1, 2027
City of Hope Medical CenterPhase 1 NCT02432963 Registry history of NCT02432963 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jul 1, 2026 to Dec 15, 2027
Alliance for Clinical Trials in OncologyPhase 3 NCT04094688 Registry history of NCT04094688 on ClinicalTrials.gov (opens the registry)
Start date pushed from Sep 8, 2026 to Oct 6, 2026
Hoffmann-La RochePhase 1 NCT07416552 Registry history of NCT07416552 on ClinicalTrials.gov (opens the registry)
Interventions modified
ExelixisPhase 1 NCT05176483 Registry history of NCT05176483 on ClinicalTrials.gov (opens the registry)
Interventions modified
Also in this update: Study completion moved earlier from Jun 30, 2034 to Jun 30, 2029
ECOG-ACRIN Cancer Research GroupPhase 3 NCT05863195 Registry history of NCT05863195 on ClinicalTrials.gov (opens the registry)
Start date changed from estimate of Sep 21, 2026 to Oct 14, 2026
George Washington UniversityNot applicable NCT07220018 Registry history of NCT07220018 on ClinicalTrials.gov (opens the registry)
Interventions modified
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2/3 NCT06958432 Registry history of NCT06958432 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 31, 2029 to Dec 31, 2031
Also in this update: Primary completion moved earlier from Sep 30, 2029 to Jul 31, 2029
Emory UniversityPhase 2 NCT07140679 Registry history of NCT07140679 on ClinicalTrials.gov (opens the registry)
Interventions modified
The Netherlands Cancer InstitutePhase 2 NCT03026140 Registry history of NCT03026140 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Oct 2029 to Apr 6, 2026
University of ChicagoPhase 1/2 NCT06349590 Registry history of NCT06349590 on ClinicalTrials.gov (opens the registry)
Study completion pushed from May 31, 2026 to May 31, 2027
Also in this update: Primary completion date changed from estimate of Dec 1, 2025 to Mar 1, 2026
Louisiana State University Health Sciences Center ShreveportNot applicable NCT04313114 Registry history of NCT04313114 on ClinicalTrials.gov (opens the registry)
Primary and study completion moved earlier from Dec 1, 2026 to Nov 1, 2026
Washington University School of MedicineNot applicable NCT06910670 Registry history of NCT06910670 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 11, 2026 to Jul 14, 2027
City of Hope Medical CenterNot applicable NCT02293954 Registry history of NCT02293954 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Mar 2027 to Jul 2, 2026
H. Lee Moffitt Cancer Center and Research InstituteNot applicable NCT06337552 Registry history of NCT06337552 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Jul 2024); last known: Recruiting
AUM Biosciences Pte LtdPhase 2 NCT05462236 Registry history of NCT05462236 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Recruiting
Chongqing Precision Biotech Co., LtdPhase 1 NCT06010862 Registry history of NCT06010862 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Nov 2023); last known: Recruiting
Tanta UniversityPhase 3 NCT06134388 Registry history of NCT06134388 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Centre Hospitalier Universitaire de BesanconPhase 3 NCT05168839 Registry history of NCT05168839 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Sir Run Run Shaw HospitalPhase 2 NCT06594692 Registry history of NCT06594692 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Recruiting
N.N. Petrov National Medical Research Center of OncologyPhase 2 NCT06229340 Registry history of NCT06229340 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 1/2 NCT06202001 Registry history of NCT06202001 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Not Yet Recruiting
Harbin Medical UniversityPhase 2 NCT06192680 Registry history of NCT06192680 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Nov 2023); last known: Recruiting
The First Affiliated Hospital of Nanchang UniversityPhase 4 NCT06118762 Registry history of NCT06118762 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fudan UniversityPhase 2 NCT05963490 Registry history of NCT05963490 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fudan UniversityPhase 2 NCT05628038 Registry history of NCT05628038 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Active, Not Recruiting
Anup KasiPhase 1/2 NCT05121038 Registry history of NCT05121038 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Academic and Community Cancer Research UnitedPhase 2 NCT04117945 Registry history of NCT04117945 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Seoul National University HospitalNot applicable NCT06759844 Registry history of NCT06759844 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNot specified NCT06653478 Registry history of NCT06653478 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Istituto Clinico HumanitasNot applicable NCT06615583 Registry history of NCT06615583 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Western University, CanadaNot applicable NCT06615648 Registry history of NCT06615648 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
First Affiliated Hospital of Chongqing Medical UniversityNot specified NCT06614699 Registry history of NCT06614699 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Catholic University of the Sacred HeartNot specified NCT06607614 Registry history of NCT06607614 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
First Affiliated Hospital of Chongqing Medical UniversityNot specified NCT06606912 Registry history of NCT06606912 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Shanghai 10th People's HospitalNot specified NCT06601985 Registry history of NCT06601985 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Fudan UniversityNot applicable NCT06588569 Registry history of NCT06588569 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Tata Memorial CentreNot specified NCT06252142 Registry history of NCT06252142 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Not Yet Recruiting
Kuban State Medical UniversityNot applicable NCT06066931 Registry history of NCT06066931 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Centre Hospitalier Universitaire de Saint EtienneNot specified NCT06024837 Registry history of NCT06024837 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
National Taiwan University HospitalNot applicable NCT05970133 Registry history of NCT05970133 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
National Taiwan University HospitalNot specified NCT05961969 Registry history of NCT05961969 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Apr 2023); last known: Not Yet Recruiting
Assiut UniversityNot specified NCT05850559 Registry history of NCT05850559 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University Hospital, GhentNot applicable NCT03779009 Registry history of NCT03779009 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-16 | NCT07878988 This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of… | LTZ Therapeutics, Inc. new | Phase 1 |
| 2026-10-15 | NCT07874880 MTX-531-001 Phase 1 Study in Advanced Solid Tumors | MEKanistic Therapeutics, Inc. new | Phase 1 |
| 2026-10-15 | NCT07875920 Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation | Neowise Biotechnology new | Phase 1 |
| 2026-10-15 | NCT07875465 Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid… | Bing Xia new | Phase 2 |
| 2026-10-14 | NCT07874035 Low Load Blood Flow Restriction Resistance Training in Colorectal Cancer Related… | Ahmed Adel Ahmed Elsayed Ali Radwan new | |
| 2026-10-14 | NCT07873450 SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET | Full-Life Technologies UK Limited new | Phase 1/2 |
| 2026-10-07 | NCT07863154 Probiotic Supplementation During Neoadjuvant Chemoradiotherapy in Colorectal Cancer | University of Malaga new | |
| 2026-09-30 | NCT07850778 ONS USE IN COLON CANCER | Osmaniye Korkut Ata University new | |
| 2026-09-30 | NCT07850882 A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection… | Jie Yuan，MD new | |
| 2026-09-28 | NCT07844187 TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for… | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. new | Phase 1/2 |
| Early Phase 1 | 33 | |
| Phase 1 | 278 | |
| Phase 1/2 | 215 | |
| Phase 2 | 608 | |
| Phase 2/3 | 45 | |
| Phase 3 | 189 | |
| Phase 4 | 27 |
Fudan University (84) · Sun Yat-sen University (71) · M.D. Anderson Cancer Center (51) · National Cancer Institute (NCI) (49) · Sixth Affiliated Hospital, Sun Yat-sen University (34) · City of Hope Medical Center (33) · Memorial Sloan Kettering Cancer Center (30) · Peking University Cancer Hospital & Institute (22) · Second Affiliated Hospital, Zhejiang University, School of Medicine (21) · Massachusetts General Hospital (20)